Skip to content

UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients

A Non-interventional Observational Study of Infectious Complications in Cancer Patients

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01622595
Enrollment
0
Registered
2012-06-19
Start date
2009-11-30
Completion date
2015-12-31
Last updated
2015-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspergillosis, Candidemia, C. Difficile

Keywords

Aspergillosis, Candidemia, Candidiasis, C. Difficile, cytomegalovirus, respiratory syncytial virus (RSV), Influenza, CONS

Brief summary

OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS

Detailed description

A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS

Interventions

None listed

Sponsors

University of Arkansas
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* cancer patients with Infections

Exclusion criteria

* No Infections

Design outcomes

Primary

MeasureTime frameDescription
To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients3 yearsTo study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients

Secondary

MeasureTime frameDescription
incidence3 yearsTo determine the overall incidence of different infections, including bacterial, fungal and viral infections in cancer patients receiving chemotherapy and / or hematopoietic stem cell transplantation. * To describe the natural history of such infections in cancer patients. * To monitor the adherence of Myeloma institute for research and therapy(MIRT) health care workers to the MIRT standard operational procedures (SOPs) * To identify risk factors for the development of specific infections. * To validate surrogate markers as early diagnostic tools for various infections.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026